Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Intensive Care Medicine
Erschienen in: Intensive Care Medicine 7/2009

01.07.2009 | Original

Short-term evaluation of sedation with sevoflurane administered by the anesthetic conserving device in critically ill patients

verfasst von: Maurizio Migliari, Giacomo Bellani, Roberto Rona, Stefano Isgrò, Beatrice Vergnano, Tommaso Mauri, Nicolò Patroniti, Antonio Pesenti, Giuseppe Foti

Erschienen in: Intensive Care Medicine | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Assessing feasibility and physiological effects of sedation with sevoflurane, administered with the anesthetic conserving device (AnaConDa), in comparison with propofol and remifentanil.

Methods

Seventeen patients undergoing mechanical ventilation underwent sedation with sevoflurane delivered with AnaConDa (phase SevAn), preceded and followed by sedation with propofol and remifentanil (phases ProRe1, ProRe2), with the same sedation targets.

Results

With both strategies it was possible to achieve the sedation targets. Time required to sedate and awake patients was greater during SevAn than ProRe1: respectively, 3.3 ± 3.0 versus 8.9 ± 6.1 and 7.47 ± 5.05 versus 16.3 ± 11.4 min. During SevAn the PaCO2 and minute ventilation increased. Hemodynamics was stable between ProRe1 and SevAn, except for an increase in heart rate in the SevAn phase. Environmental pollution from sevoflurane was within the safety limits.

Conclusions

Sevoflurane can be effectively and safely used for short-term sedation of ICU patients with stable hemodynamic conditions.
Literatur
1.
Sessler CN, Varney K (2008) Patient-focused sedation and analgesia in the ICU. Chest 133:552–565PubMedCrossRef
2.
Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, Chalfin DB, Masica MF, Bjerke HS, Coplin WM, Crippen DW, Fuchs BD, Kelleher RM, Marik PE, Nasraway SA Jr, Murray MJ, Peruzzi WT, Lumb PD (2002) Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 30:119–141PubMedCrossRef
3.
Ostermann ME, Keenan SP, Seiferling RA, Sibbald WJ (2000) Sedation in the intensive care unit: a systematic review. JAMA 283:1451–1459PubMedCrossRef
4.
Ebert TJ (2006) Inhalation Anesthesia. In: Barash PG, Cullen BF, Stoelting RK (eds) Clinical anesthesia. Lippincott Williams & Wilkins, Philadelphia, pp 384–420
5.
Patel SS, Goa KL (1996) Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia. Drugs 51:658–700PubMedCrossRef
6.
Sackey PV, Martling CR, Granath F, Radell PJ (2004) Prolonged isoflurane sedation of intensive care unit patients with the anesthetic conserving device. Crit Care Med 32:2241–2246PubMed
7.
Rohm KD, Wolf MW, Schollhorn T, Schellhaass A, Boldt J, Piper SN (2008) Short-term sevoflurane sedation using the anaesthetic conserving device after cardiothoracic surgery. Intensive Care Med 34:1683–1689PubMedCrossRef
8.
Belda JF, Soro M, Badenes R, Meiser A, Garcia ML, Aguilar G, Marti FJ (2008) The predictive performance of a pharmacokinetic model for manually adjusted infusion of liquid sevofluorane for use with the anesthetic-conserving device (AnaConDa): a clinical study. Anesth Analg 106:1207–1214PubMedCrossRef
9.
Meyer JU, Kullik G, Wruck N, Kuck K, Manigel J (2008) Advanced technologies and devices for inhalational anesthetic drug dosing. Handb Exp Pharmacol 182:451–470
10.
Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O’Neal PV, Keane KA, Tesoro EP, Elswick RK (2002) The Richmond agitation-sedation scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 166:1338–1344PubMedCrossRef
11.
Singh H (1999) Bispectral index (BIS) monitoring during propofol-induced sedation and anaesthesia. Eur J Anaesthesiol 16:31–36PubMed
12.
Rossi A, Polese G, Milic-Emili J (1998) Monitoring respiratory mechanics in ventilator-dependent patients. In: Tobin M (ed) Principles and practice of intensive care monitoring. McGraw Hill, New York, pp 553–596
13.
Sackey PV, Martling CR, Nise G, Radell PJ (2005) Ambient isoflurane pollution and isoflurane consumption during intensive care unit sedation with the anesthetic conserving device. Crit Care Med 33:585–590PubMedCrossRef
14.
Accorsi A, Valenti S, Barbieri A, Raffi GB, Violante FS (2003) Proposal for single and mixture biological exposure limits for sevoflurane and nitrous oxide at low occupational exposure levels. Int Arch Occup Environ Health 76:129–136PubMed
15.
Malan TP Jr, DiNardo JA, Isner RJ, Frink EJ Jr, Goldberg M, Fenster PE, Brown EA, Depa R, Hammond LC, Mata H (1995) Cardiovascular effects of sevoflurane compared with those of isoflurane in volunteers. Anesthesiology 83:918–928PubMedCrossRef
16.
Yeo ST, Holdcroft A, Yentis SM, Stewart A (2007) Analgesia with sevoflurane during labour: i. Determination of the optimum concentration. Br J Anaesth 98:105–109PubMedCrossRef
17.
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The acute respiratory distress syndrome network (2000) N Engl J Med 342:1301–1308
18.
Metadaten
Titel
Short-term evaluation of sedation with sevoflurane administered by the anesthetic conserving device in critically ill patients
verfasst von
Maurizio Migliari
Giacomo Bellani
Roberto Rona
Stefano Isgrò
Beatrice Vergnano
Tommaso Mauri
Nicolò Patroniti
Antonio Pesenti
Giuseppe Foti
Publikationsdatum
01.07.2009
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 7/2009
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-009-1414-7

Weitere Artikel der Ausgabe 7/2009

Intensive Care Medicine 7/2009 Zur Ausgabe

Correspondence

Recurrent malaise and oedema in a 35-year-old female

Correspondence

Blood and tissue glucose level in critically ill patients: a comparison of different methods of measuring interstitial glucose levels

Correspondence

Comment on “A comparison of epinephrine and norepinephrine in critically Ill patients”

Correspondence

Acute renal failure due to severe rhabdomyolysis: a rare clinical manifestation of atrial myxoma

Original

Comparison of acceptability, skin tolerance, and compliance between handwashing and alcohol-based handrub in ICUs: results of a multicentric study

Correspondence

Costs of intermittent measurement of central venous oxygen saturations by blood gas analysis

Neu im Fachgebiet AINS

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Leitsymptom Rückenschmerzen | Nachrichten

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 | Pankreaskarzinom | Nachrichten

S3-Leitlinie zu Pankreaskrebs aktualisiert
weitere anzeigen

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren